 |
|
|
| |
EIGHT WEEKS TREATMENT DURATION WITH LEDIPASVIR/SOFOSBUVIR (LDV/SOF) IS EFFECTIVE FOR APPROPRIATELY SELECTED PATIENTS WITH GENOTYPE 1 HEPATITIS C VIRUS (HCV) INFECTION: AN ANALYSIS OF MULTIPLE REAL WORLD COHORTS TOTALING >6,500 PATIENTS
|
| |
| |
Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
Vinay Sundaram1, Christie Y. Jeon1, Kamran Qureshi2, Nyan L. Latt3, Amandeep K. Sahota3, Michael P. Curry4, Naoky C. Tsai5, Nathorn Chaiyakunapruk6, Yoori Lee7, Stephen L. Lott8, Jorg Petersen9, Peter Buggisch9, Kris V. Kowdley10 1Cedars-Sinai Medical Center, 2Temple University Lewis Katz School of Medicine, 3Kaiser Permanente Los Angeles Medical Center, 4Beth Israel Deaconess Medical Center, 5University of Hawaii, 6Monash University, 7TRIO Health Analytics, 8Burmans-Diplomat Specialty Pharmacy, 9Institut für Interdisziplinäre Medizin, 10Swedish Medical Center
|
| |
|
|
|
|
|
